Photocure ASA (PHCUF)

Market Cap	147.44M
Revenue (ttm)	50.64M
Net Income (ttm)	203.24K
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	725.45
Forward PE	157.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	742
Open	5.49
Previous Close	n/a
Day's Range	5.49 - 5.49
52-Week Range	4.32 - 5.60
Beta	0.61
RSI	47.35
Earnings Date	Jul 30, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 101
• Stock Exchange: OTCMKTS
• Ticker Symbol: PHCUF

Financial Performance

Financial numbers in NOK